WO2007124448A3 - Method and apparatus for the management of diabetes - Google Patents

Method and apparatus for the management of diabetes Download PDF

Info

Publication number
WO2007124448A3
WO2007124448A3 PCT/US2007/067132 US2007067132W WO2007124448A3 WO 2007124448 A3 WO2007124448 A3 WO 2007124448A3 US 2007067132 W US2007067132 W US 2007067132W WO 2007124448 A3 WO2007124448 A3 WO 2007124448A3
Authority
WO
WIPO (PCT)
Prior art keywords
levels
materials component
biologic materials
diabetes
management
Prior art date
Application number
PCT/US2007/067132
Other languages
French (fr)
Other versions
WO2007124448A2 (en
Inventor
Spencer Z Rosero
Original Assignee
Spencer Z Rosero
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spencer Z Rosero filed Critical Spencer Z Rosero
Publication of WO2007124448A2 publication Critical patent/WO2007124448A2/en
Publication of WO2007124448A3 publication Critical patent/WO2007124448A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/022—Artificial gland structures using bioreactors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/03—Detecting, measuring or recording fluid pressure within the body other than blood pressure, e.g. cerebral pressure; Measuring pressure in body tissues or organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/07—Endoradiosondes
    • A61B5/076—Permanent implantations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0001—Means for transferring electromagnetic energy to implants

Abstract

A biological chip device having a biologic materials component according to embodiments of the invention may provide the ability to sense levels of blood parameters (e.g., glucose, insulin, and glucagon levels) in a patient. In certain embodiments of the invention, a device may include therapeutic abilities in which a portion of the biologic materials component produces a drug to treat the underlying disease in response to measured or sensed blood parameter levels.
PCT/US2007/067132 2006-04-20 2007-04-20 Method and apparatus for the management of diabetes WO2007124448A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79421706P 2006-04-20 2006-04-20
US60/794,217 2006-04-20

Publications (2)

Publication Number Publication Date
WO2007124448A2 WO2007124448A2 (en) 2007-11-01
WO2007124448A3 true WO2007124448A3 (en) 2008-05-08

Family

ID=38625780

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/067132 WO2007124448A2 (en) 2006-04-20 2007-04-20 Method and apparatus for the management of diabetes

Country Status (2)

Country Link
US (3) US20070249007A1 (en)
WO (1) WO2007124448A2 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7927869B2 (en) * 2005-11-29 2011-04-19 Spencer Z Rosero System and method for supporting a biological chip device
US20090205961A1 (en) * 2006-06-02 2009-08-20 Koninklijke Philips Electronics N.V. Separation device comprising a surfactant releasing means
US20090120810A1 (en) * 2007-11-02 2009-05-14 Edwards Lifesciences Corporation Analyte monitoring system capable of detecting and providing protection against signal noise generated by external systems that may affect the monitoring system
US20090188811A1 (en) * 2007-11-28 2009-07-30 Edwards Lifesciences Corporation Preparation and maintenance of sensors
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
US9146230B2 (en) 2011-06-20 2015-09-29 Yoram Palti Continuous monitoring of glucose and other living body constituents
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
CN111905188B (en) 2015-02-18 2022-07-22 英赛罗公司 Fluid delivery and infusion device and method of use
EP3374905A1 (en) 2016-01-13 2018-09-19 Bigfoot Biomedical, Inc. User interface for diabetes management system
CN112933333B (en) 2016-01-14 2023-03-28 比格福特生物医药公司 Adjusting insulin delivery rate
WO2017143153A1 (en) 2016-02-19 2017-08-24 North Carolina State University Methods and compositions related to physiologically responsive microneedle delivery systems
WO2018058041A1 (en) * 2016-09-23 2018-03-29 Insulet Corporation Fluid delivery device with sensor
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
CA3099113A1 (en) 2018-05-04 2019-11-07 Insulet Corporation Safety constraints for a control algorithm-based drug delivery system
CN112789070A (en) 2018-09-28 2021-05-11 英赛罗公司 Mode of activity of the artificial pancreas System
US11565039B2 (en) 2018-10-11 2023-01-31 Insulet Corporation Event detection for drug delivery system
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
KR20220020108A (en) * 2020-08-11 2022-02-18 삼성전자주식회사 Drug delivery device and method for operating the same
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
US11738144B2 (en) 2021-09-27 2023-08-29 Insulet Corporation Techniques enabling adaptation of parameters in aid systems by user input
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4240438A (en) * 1978-10-02 1980-12-23 Wisconsin Alumni Research Foundation Method for monitoring blood glucose levels and elements
US5741211A (en) * 1995-10-26 1998-04-21 Medtronic, Inc. System and method for continuous monitoring of diabetes-related blood constituents

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190041A (en) * 1989-08-11 1993-03-02 Palti Yoram Prof System for monitoring and controlling blood glucose
US5474552A (en) * 1994-06-27 1995-12-12 Cb-Carmel Biotechnology Ltd. Implantable drug delivery pump
US5545531A (en) * 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
AU6898996A (en) * 1995-08-21 1997-03-12 Cytrx Corporation Compositions and methods for growth promotion
US5711861A (en) * 1995-11-22 1998-01-27 Ward; W. Kenneth Device for monitoring changes in analyte concentration
US6221654B1 (en) * 1996-09-25 2001-04-24 California Institute Of Technology Method and apparatus for analysis and sorting of polynucleotides based on size
US6165748A (en) * 1997-07-11 2000-12-26 Genetics Institute, Inc. Frazzled nucleotide sequences and expression products
US6117643A (en) * 1997-11-25 2000-09-12 Ut Battelle, Llc Bioluminescent bioreporter integrated circuit
US6884215B1 (en) * 1998-05-28 2005-04-26 Carmel Biosensors Ltd. Frequency estimation of electro-islet-graphy
US6650919B2 (en) * 2000-05-03 2003-11-18 Cornell Research Foundation, Inc. Enhanced biologically based chronotropic biosensing
US6605039B2 (en) * 2000-07-24 2003-08-12 Medtronic, Inc. Cell-based biosensors suitable for implantable medical device applications
US20050026134A1 (en) * 2002-04-10 2005-02-03 Bioprocessors Corp. Systems and methods for control of pH and other reactor environment conditions
US7507579B2 (en) * 2002-05-01 2009-03-24 Massachusetts Institute Of Technology Apparatus and methods for simultaneous operation of miniaturized reactors
WO2005084257A2 (en) * 2004-02-26 2005-09-15 Vpn Solutions, Llc Composite thin-film glucose sensor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4240438A (en) * 1978-10-02 1980-12-23 Wisconsin Alumni Research Foundation Method for monitoring blood glucose levels and elements
US5741211A (en) * 1995-10-26 1998-04-21 Medtronic, Inc. System and method for continuous monitoring of diabetes-related blood constituents

Also Published As

Publication number Publication date
US20110217349A1 (en) 2011-09-08
US20130045521A1 (en) 2013-02-21
WO2007124448A2 (en) 2007-11-01
US20070249007A1 (en) 2007-10-25

Similar Documents

Publication Publication Date Title
WO2007124448A3 (en) Method and apparatus for the management of diabetes
WO2006069677A3 (en) Combination comprising an agent providing a signal, an implant material and a drug
SI1957135T1 (en) Device for automatic regulation of the concentration of glucose in the blood of a diabetes patient
EP2518655A3 (en) Device and method for preventing hypoglycemia
WO2007081947A3 (en) Drug storage and dispensing devices and systems comprising the same
WO2005083621A3 (en) Advanced patient and medication therapy management system and method
AU2003215064A8 (en) Autonomous, ambulatory analyte monitor or drug delivery device
EP2036574A4 (en) Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance
IL226046A (en) 2-((1r,4r)-4-(4-(5-(benzo[d]oxazol-2-ylamino)pyridin-2-yl)phenyl)cyclohexyl)acetic acid and use thereof in the preparation of a medicament for the treatment of impaired glucose tolerance, type 2 diabetes and obesity
WO2011020319A8 (en) Fusion protein regulating plasma glucose and lipid, its preparation method and use
WO2007126918A3 (en) Device and method of spacer and trial design during joint arthroplasty
WO2007130436A3 (en) Clip-style medical sensor including a pressure stopper element
WO2005011787A3 (en) Apparatus and method for treating intravascular disease
IL196296A0 (en) Manufacture, method, and use of active substance-releasing medical products for permanently keeping blood vessels open
WO2007120936A3 (en) Use.of vildagliptin for the treatment of diabetes
WO2007133776A3 (en) Active delivery and flow redirection: novel devices and method of delivery of materials to patients
WO2006035443A3 (en) Monitoring of convection enhanced drug delivery
EP2486924A3 (en) Drugs and uses
WO2007011955A3 (en) Drug-containing implants and methods of use thereof
WO2008039923A3 (en) Two part antimicrobial boot
EP1888143B8 (en) Disposable cartridge, and apparatus for the blood treatment
WO2007120557A3 (en) Method and apparatus of low strengh electric field network-mediated delivery
ATE539676T1 (en) DEVICE FOR ADMINISTRATION OF AN IMPLANTABLE MONITOR
BRPI0919560A2 (en) device for extracorporeal blood treatment in single needle mode of operation and method for operating a device for extracorporeal blood treatment
ZA201000990B (en) Herbal formulations for controlling blood glucose levels in patients with diabetes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07761050

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07761050

Country of ref document: EP

Kind code of ref document: A2